Literature DB >> 12230467

1st class ticket to class I: protein toxins as pathfinders for antigen presentation.

Daniel C Smith1, J Michael Lord, Lynne M Roberts, Eric Tartour, Ludger Johannes.   

Abstract

A number of bacterial toxins have evolved diverse strategies for crossing membrane barriers in order to reach their substrates in the mammalian cytosol. Recent studies show that this property can be exploited for the delivery of fused antigens into the major histocompatibility complex class I-restricted presentation pathway, with the goal of eliciting a specific immune response. Here we discuss the peculiarities of the trafficking pathways of a variety of toxins, and how these may allow the toxins to be used as delivery vehicles for therapeutic and diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230467     DOI: 10.1034/j.1600-0854.2002.31001.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  14 in total

Review 1.  Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.

Authors:  Maria Teresa Tarragó-Trani; Brian Storrie
Journal:  Adv Drug Deliv Rev       Date:  2007-06-28       Impact factor: 15.470

Review 2.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

Review 3.  Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Authors:  Mevyn Nizard; Mariana O Diniz; Helene Roussel; Thi Tran; Luis Cs Ferreira; Cecile Badoual; Eric Tartour
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 4.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

5.  Stimulation of CD8+ T cells following diphtheria toxin-mediated antigen delivery into dendritic cells.

Authors:  Christine A Shaw; Michael N Starnbach
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  TLR4-MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide.

Authors:  Yuji Kondo; Kazutaka Ikeda; Noriyo Tokuda; Chiaki Nishitani; Umeharu Ohto; Sachiko Akashi-Takamura; Yasutomo Ito; Makoto Uchikawa; Yoshio Kuroki; Ryo Taguchi; Kensuke Miyake; Qing Zhang; Keiko Furukawa; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-05       Impact factor: 11.205

7.  [Paraoxonase 1 gene polymorphism 192Q/R in old men and long-livers from Tatars ethnic group].

Authors:  V V Pauk; I A Tuktarova; T R Nasibullin; L P Zueva; A Kh Adel'guzhina; E K Khusnutdinova; O E Mustafina
Journal:  Mol Biol (Mosk)       Date:  2007 Jul-Aug

8.  Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea Pigs.

Authors:  Sreerupa Challa; Steven M Szczepanek; Debra Rood; Roger W Barrette; Lawrence K Silbart
Journal:  Adv Virol       Date:  2011-09-22

Review 9.  Therapeutic Uses of Bacterial Subunit Toxins.

Authors:  Clifford Lingwood
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

Review 10.  Retrograde traffic in the biosynthetic-secretory route.

Authors:  Margit Pavelka; Josef Neumüller; Adolf Ellinger
Journal:  Histochem Cell Biol       Date:  2008-02-13       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.